7R6-12832-15765
3 vaccinations
5 coded responses
28 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 232 / VA
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Registered in v-safe
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Good · HeadacheFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Diarrhea · Be unable to workFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Fever · DiarrheaFree text: Not as bad as yesterday; not concernedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-12-01
Dose 3 — Pfizer-BioNTech
-
2021-12-30
Survey response — day 28, dose 3MedDRA: Ageusia, Anosmia, Diarrhoea, Headache, Lethargy, Lymphadenopathy, Oropharyngeal pain, Stomatitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased lethargy, diarrhea 1-3 x's week, swollen gland/sore throat/sore spots in mouth (getting better with sea salt warm water), low grade headache, still on and off ability to smell/tasteMedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-01-12
- 2022-03-02
- 2022-06-01
-
2022-12-01
Survey response — 12 months, dose 3MedDRA: Fatigue, Office visit, Post-acute COVID-19 syndrome, Pre-existing disease, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: I have been diagnosed as Long Haul COVID; chronic/extreme fatigue, Cognitive/Brain, lung and possible heart damage as a result. · Healthcare visit (other): Neuropsych, evaluation, Neuropsychological TestingMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 0, dose 2
Systemic reaction (other): No
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): Not as bad as yesterday; not concerned
Release 10 — day 28, dose 3
Symptoms: Increased lethargy, diarrhea 1-3 x's week, swollen gland/sore throat/sore spots in mouth (getting better with sea salt warm water), low grade headache, still on and off ability to smell/taste
Release 12 — 12 months, dose 3
Symptoms: I have been diagnosed as Long Haul COVID; chronic/extreme fatigue, Cognitive/Brain, lung and possible heart damage as a result.
Healthcare visit (other): Neuropsych, evaluation, Neuropsychological Testing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Stomatitis | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release